EUVIMEDEUVIMED entdecken
Crossref

Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants

Wei Du, Ida Marie Boisen, Sabrina N Rahman, Nadia Nicholine Poulsen, Jesper M Mathiesen, Martin Blomberg Jensen, Hans Bräuner-Osborne iD, Anders A Jensen iD

The Journal of Clinical Endocrinology & Metabolism · 17.06.2025 · 110 (7) · 1865-1880

DOI: 10.1210/clinem/dgae735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 16.10.2024. Verfasst von Wei Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark. Hauptthemen laut MEDLINE: Receptors, Calcium-Sensing, Hypercalcemia, Calcium, Hypoparathyroidism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Novo Nordisk Foundation, Lundbeck Foundation Experiment, Independent Research Fund Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The human calcium-sensing receptor (CaSR) plays a key role in calcium homeostasis, and most identified CASR variants are associated with hypercalcemic and hypocalcemic disorders.

Objective

Here we characterized the pharmacological implications of 5 heterozygous CASR variants from individuals with familial hypocalciuric hypercalcemia 1 (FHH1: Y63C, I81T, Q459R, W818stop) or autosomal dominant hypocalcemia 1 (ADH1: R955stop).

Methods

Total and cell surface expression levels of wild-type (WT) and variant CaSRs expressed in human embryonic kidney 293T (HEK293T) cells were determined using enzyme-linked immunosorbent assay, and the pharmacological properties of the receptors were delineated in 2 functional assays.

Results

The Y63C and I81T variations in the extracellular domain (ECD) of CaSR yielded markedly reduced cell surface expression and Ca2+ responsiveness, while Q459R displayed WT-like expression and functional properties. Truncation of the 7-transmembrane domain (7TMD) in W818stop eliminated cell surface expression, whereas R955stop in the intracellular carboxy-terminal yielded modestly increased surface expression and Ca2+ potency compared with WT CaSR. Interestingly, the effectiveness of positive allosteric modulators (PAMs) at the variants varied. Ca2+-mediated signaling through Y63C and I81T was significantly augmented by 7TMD-binding PAMs (NPS R-568 and evocalcet) but not by ECD-binding PAMs (etelcalcetide and Nb4), whereas signaling through Q459R and R955stop were robustly potentiated by all four PAMs.

Conclusion

While the molecular phenotypes exhibited by the 5 CaSR variants concord with the clinical phenotypes in individuals harboring them, CASR variant–induced calcium homeostasis disorders clearly arise from diverse molecular origins, and the effectiveness of calcimimetics in these disorders could differ depending on the specific variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Calcium-SensingHypercalcemiaCalciumHypoparathyroidismHypercalciuriaHypocalcemiaHumansHomeostasisHEK293 CellsHeterozygoteMaleFemale

Stichwörter der Autor:innen

CASRcalcium-sensing receptor (CaSR)genetic variantshypercalcemiahypocalcemia

Substanzen

Receptors, Calcium-SensingCalciumCASR protein, human

Autor:innen und Institutionen

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark.
  • Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, University Hospital Copenhagen, Herlev-Gentofte, DK-2730 Herlev, Denmark.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, DK-2200 Copenhagen N, Denmark.

ORCID-Profile: Hans Bräuner-Osborne, Anders A Jensen

Förderung

  • Novo Nordisk Foundation
  • Lundbeck Foundation Experiment
  • Independent Research Fund Denmark
  • China Scholarship Council

Zitieren

APA

Du, W., Boisen, I. M., Rahman, S. N., Poulsen, N. N., Mathiesen, J. M., Blomberg Jensen, M., Bräuner-Osborne, H., & Jensen, A. A. (2025). Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants. The Journal of Clinical Endocrinology & Metabolism, 110(7), 1865-1880. https://doi.org/10.1210/clinem/dgae735

Vancouver

Du W, Boisen IM, Rahman SN, Poulsen NN, Mathiesen JM, Blomberg Jensen M, et al. Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants. The Journal of Clinical Endocrinology & Metabolism. 2025;110(7):1865-1880. doi:10.1210/clinem/dgae735

BibTeX
@article{Du2025,
  author = {Du, Wei and Boisen, Ida Marie and Rahman, Sabrina N and Poulsen, Nadia Nicholine and Mathiesen, Jesper M and Blomberg Jensen, Martin and Bräuner-Osborne, Hans and Jensen, Anders A},
  title = {Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {7},
  pages = {1865--1880},
  doi = {10.1210/clinem/dgae735}
}
Kostenlos starten →